• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."

    --Gandhi

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Vote!

Cariprazine Found to Be Effective and Well-Tolerated for Bipolar Depression

An eight-week, randomized, controlled study published today in AJP in Advance has found that a 1.5 mg daily dose of the atypical antipsychotic cariprazine can reduce depressive symptoms in people with bipolar I disorder experiencing a major depressive episode.Most antipsychotics are approved to treat bipolar manic or mixed episodes, but currently only lurasidone and quetiapine are approved for bipolar depression (lurasidone has not been assessed in bipolar mania and is not indicated for its treatment). Cariprazine (trade name Vraylar) was recently approved by the FDA for the acute treatment of...

read more...

Share |

Published By: Psychiatric News - Friday, 6 November, 2015

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.